Discover 409 paid clinical trials in Lexington, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Location: Lexington KY, Skokie IL, Summerville SC, Harrisburg PA,
Sponsor: TScan Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06587828
Recruiting
Active & Responsive
Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)
for
Diabetes Mellitus, Type 2
Location: Lexington KY, Knoxville TN, Springfield MO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 24 - 70+
Code: NCT07089784
Phase1, Recruiting
Active & Responsive
Brief Exposure and Exercise for PTSD.
for
PTSD - Post Traumatic Stress Disorder
Location: Lexington KY
Sponsor: Troy Hubert
Sex: All
Age: 18 - 64
Code: NCT07080606
Recruiting
Active & Responsive
Exercise and Emotional Learning in Posttraumatic Stress Disorder
for
PTSD
Location: Lexington KY, Austin TX
Sponsor: Christal L Badour
Sex: All
Age: 18 - 64
Code: NCT06127342
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee
for
Osteoarthritis (OA) of the Knee
Location: Lexington KY, Marietta GA, Altoona PA, State College PA,
Sponsor: OrthoTrophix, Inc
Sex: All
Age: 50 - 70+
Code: NCT06865079
Phase2, Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Hypertension,
Location: Lexington KY, Cincinnati OH, Bowling Green KY,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07064473
Phase3, Recruiting
Active & ResponsiveNew
Shared Decision Making to Treat Or Prevent (STOP) HIV in Justice Populations (R33)
for
Substance Use Disorders
Location: Lexington KY, New Haven CT, Fort Worth TX
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT07223398
Recruiting
Active & ResponsiveNew
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age